$104.51 -1.25 (%) SPDR S&P Phrmct Shs - NYSEARCA

Oct. 22, 2014 | 04:00 PM

Partner Headlines

  1. Is Akorn, Inc. An Easy Buy This Week?

    Benzinga | Sep. 16, 2014 | 20:17PM EST
  2. 3 Ways to Profit from Merger Activity in the Pharmaceutical Sector

    Benzinga | Apr. 25, 2014 | 10:20AM EST
  3. Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga | Apr. 22, 2014 | 13:24PM EST
  4. A Tale of Two Headlines

    Benzinga | Apr. 4, 2014 | 11:01AM EST
  5. Pharmaceutical Industry Expected To Collect Billions From Obamacare

    Benzinga | Oct. 2, 2013 | 12:51PM EST
  6. S&P: Heaping Praise For Some Health Care ETFs

    Benzinga | Aug. 2, 2013 | 16:00PM EST
  7. S&P Reiterates Bullish View on Health Care ETFs

    Benzinga | Nov. 16, 2012 | 05:56AM EST
  8. These ETFs Have Stellar Dividend Growth

    Benzinga | Oct. 9, 2012 | 08:58AM EST
  9. The outperforming pharmaceutical sector remains plagued by pessimism

    SchaeffersResearch | Jun. 22, 2012 | 11:52AM EST
  10. Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)

    Benzinga | Feb. 22, 2012 | 17:05PM EST
  11. Can This Pharmaceutical Company Make You Rich?

    Benzinga | Jan. 6, 2012 | 05:52AM EST
  12. ETF Showdown: Fun With Pharma

    Benzinga | Dec. 30, 2011 | 09:10AM EST
Trading Center